EUNET-INNOCHRON EUNET-INNOCHRON

Sidebar

Main Menu

  • Home
  • The ACTION
    • About the ACTION
    • ACTION Objectives
    • ACTION Impact
    • ACTION Management Structure
    • Working Groups
    • Visual Identity
    • ACTION Flyer
    • Member Area
    • Forum
    • Gender equality section
  • Research & Training
    • Research
      • Ethnic neutropenia
      • COVID Questionnaire
      • Childhood AIN preceding ALL
      • The European Code of Conduct for Research Integrity
      • Templates forms/ protocols (SCNIR)
    • Training
      • AIN Training School
      • AIN Training School - PART II
      • Training Course Severe Congenital Neutropenia - A Clinical Approach
      • Training School on Biobanking on Neutropenias
      • Training School on Molecular Diagnosis of Congenital Neutropenias
      • Training School on Investigation of Human Neutrophils' Functions
    • Covid-19
  • Publications
    • Newsletters
      • Newsletter May 2020
      • Newsletter June 2021
    • Action Publications
    • Members Publications
    • EHA/EuNet-INNOCHRON Guidelines
    • ΕΗΑ/ΕuNet-INNOCHRON Treatment Guidelines
  • News-Events
  • Young INNOCHRON
  • Contact
  • Home
  • The ACTION
    • About the ACTION
    • ACTION Objectives
    • ACTION Impact
    • ACTION Management Structure
    • Working Groups
    • Visual Identity
    • ACTION Flyer
    • Member Area
    • Forum
    • Gender equality section
  • Research & Training
    • Research
      • Ethnic neutropenia
      • COVID Questionnaire
      • Childhood AIN preceding ALL
      • The European Code of Conduct for Research Integrity
      • Templates forms/ protocols (SCNIR)
    • Training
      • AIN Training School
      • AIN Training School - PART II
      • Training Course Severe Congenital Neutropenia - A Clinical Approach
      • Training School on Biobanking on Neutropenias
      • Training School on Molecular Diagnosis of Congenital Neutropenias
      • Training School on Investigation of Human Neutrophils' Functions
    • Covid-19
  • Publications
    • Newsletters
      • Newsletter May 2020
      • Newsletter June 2021
    • Action Publications
    • Members Publications
    • EHA/EuNet-INNOCHRON Guidelines
    • ΕΗΑ/ΕuNet-INNOCHRON Treatment Guidelines
  • News-Events
  • Young INNOCHRON
  • Contact
  • Forgot your password?
  • Forgot your username?
  • Don't have an account?

Please find instructions for use FORUM here.

Recent News

Recognized Excellence: Our Research Among the Top 10 Most-Cited Articles in HemaSphere!

Mar 20, 2025

Successful repurposing of empagliflozin to treat neutropenia in a severe congenital neutropenia patient with G6PC3 mutations

Nov 24, 2024

EuNet-INNOCHRON Action’s achievements and impact

Nov 06, 2024

Useful Links

COST

CA18233 Info

COST Documents and Guidelines

Privacy Policy


Social Media

We invite you to connect with EuNet-INNOCHRON on Social Media as follows


Want to find out more about EuNet-INNOCHRON?
Watch our promotional video!

Action's Chair

  • Prof Helen PAPADAKI
  • +302810394637
  • e.papadaki@uoc.gr

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

www.cost.eu

By clicking 'I Agree' you are allowing our website to store cookies on your devices to enhance user experience and monitor website usage.

View Privacy Policy

You have declined cookies. This decision can be reversed.

You have allowed cookies to be placed on your computer. This decision can be reversed.

Copyright © 2019 EuNet - Innochron.

By clicking 'I Agree' you are allowing our website to store cookies on your devices to enhance user experience and monitor website usage.

  • View Privacy Policy